Global Erythropoietin Drug Market to reach $7.8 billion by 2020, says a New Research Report at Ceskaa Research


Posted December 2, 2015 by Ceskaa

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach
 
Madison, NJ | Oct 5, 2015 | Ceskaa Research


Ceskaa Market Research (http://www.ceskaa.com/shop/pharmaceutical/global-market-for-erythropoietin-report-2014-2019/) has announced the addition of the Erythropoietin Market: 2015-2020 report to their offering.

The global erythropoietin drug market has been primarily dominated by biologics in the developed countries and by biosimilar in the developing countries. The North America region dominates the global erythropoietin drug market followed by Europe and Asia-Pacific.

The major players in the biologic erythropoietin drug market are, Amgen, Inc., Johnson & Johnson and Hoffmann-LA Roche. Sandoz (subsidiary of Novartis International AG), Hospira (subsidiary of Pfizer, Inc.), Biocon, Biosidus, 3SBio, are some of the major biosimilar players across regions.

This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs.

The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia particularly in kidney diseases and cancer globally.

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

About Ceskaa Research:

Ceskaa is a boutique market research company serving the global markets. We offer high quality market research reports on various industries. Our strong primary and secondary research teams are committed to assure the best market research reports and precise market data for your consideration.

Our research report provide useful insights, such as present and future market, competitive landscape, drivers, challenges, trends and pricing, which will help you to identify the opportunities and develop profitable business strategies. In-short the goal is to serve information you desire for a better decision making.

Ceskaa provide reports on 12 industries, which in are as follows:

 Advanced Material
 Automation & Control Process
 Biotechnology
 Chemical
 Electronics and Semiconductor
 Energy and Power
 Engineering & Manufacturing
 Food & Beverage
 Healthcare
 IT & Telecom
 Pharmaceutical
 Plastics


For more information visit: http://www.ceskaa.com/shop/pharmaceutical/global-market-for-erythropoietin-report-2014-2019/


Contact:
Tisha Thomas
Email: [email protected]
Phone: +1 973-805-7440
Website: https://ceskaa.com/
Source: Ceskaa Research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Ceskaa Research
Website https://www.ceskaa.com
Phone 973/805-7440
Business Address 300 Main Street, #123, Madison, NJ 07940 USA
Country United States
Categories Business , Marketing , Publishing
Tags erythropoietin drug
Last Updated December 2, 2015